• Annexin V-Cy5/DAPI Apoptosis Kit Workflow

  2026-08-11

  Build a rapid, two-parameter cell death workflow that separates viable, early apoptotic, late apoptotic, and membrane-compromised populations. This guide shows how the Annexin V-Cy5/DAPI Apoptosis Kit can connect phosphatidylserine exposure with the mitochondrial apoptosis mechanism reported in Ph+ ALL.

• STAU2 Condensates in Neuronal mRNA Transport

  2026-08-11

  This Advanced Science study identifies STAU2 phase-separated condensates as dynamic regulators that coordinate dendritic mRNA transport, storage, and activity-dependent translation. Its findings connect condensate material state with neuronal development and suggest that excessive or aberrant STAU2 condensation may contribute to neurodegenerative pathology.

• miR-18a, ALOXE3, and Ferroptosis in Glioblastoma

  2026-08-10

  The reference study identifies a miR-18a/ALOXE3 axis that links ferroptosis resistance with migratory behavior in glioblastoma. Its findings position ALOXE3 as a context-dependent tumor suppressor and provide a framework for studying how lipid metabolism and oxylipin signaling jointly shape GBM progression.

• Dual Luciferase Reporter Gene System for ICC

  2026-08-09

  Learn how the Dual Luciferase Reporter Gene System can function as a causal test for enhancer activity, using the ZNF263–ULK1 axis in intrahepatic cholangiocarcinoma as a practical model. This article connects assay chemistry, experimental design, normalization, and mechanistic interpretation beyond routine screening.

• Candida albicans EVs, Nrg1, and Candidemia

  2026-08-08

  This study shows that extracellular vesicles (EVs) from Candida albicans can switch from growth-supporting signals at low abundance to a self-limiting signal at high accumulation, suppressing hyphal development through the SKO1–NRG1 regulatory axis. The findings connect EV-dependent control of morphology with reduced candidemia severity in mice and provide a useful framework for studying fungal communication, virulence, and strain-dependent regulation.

• Trilaurin: From Lipid Structure to Biocatalysis

  2026-08-07

  Trilaurin, also known as Glycerol Tridodecanoate, is more than a hydrophobic excipient: its defined C12 architecture supports both enzyme-cascade research and advanced oral lipid delivery. This evidence-led guide connects molecular structure, assay design, formulation logic, and practical handling.

• Palonosetron Hydrochloride in Renal Transporter Research and

  2026-08-07

  Explore how Palonosetron hydrochloride, a highly selective 5-HT3 receptor antagonist, uniquely advances both antiemetic strategies and renal transporter assay development. This article delivers actionable scientific insights grounded in cutting-edge evidence.

• Berbamine Hydrochloride: Bridging NF-κB Inhibition and Ferro

  2026-08-06

  Berbamine hydrochloride, an isoquinoline alkaloid, is reshaping translational cancer research by targeting NF-κB and ferroptosis resistance pathways. This article synthesizes biological rationale, experimental validation, and strategic guidance for deploying this compound in advanced hepatocellular carcinoma (HCC) studies—highlighting unique mechanistic intersections, quantitative evidence, and workflow recommendations. We critically position Berbamine hydrochloride as a next-generation research tool, contextualizing its use within the evolving landscape of tumorigenesis, immunomodulation, and resistance overcoming strategies.

• Sulfo-NHS-Biotin: High-Fidelity Protein Labeling in Single-C

  2026-08-06

  Explore how Sulfo-NHS-Biotin enables precise, water-soluble protein labeling—especially in state-of-the-art single-cell and nanovial systems. This article dives deeper than standard protocols, revealing strategic assay design insights and recent advances.

• BML-277: Selective Chk2 Inhibitor for DNA Damage Response Re

  2026-08-05

  BML-277 stands out as a potent and selective Chk2 inhibitor, uniquely enabling precise interrogation of DNA damage signaling and radioprotection of T-cells. Its ATP-competitive mechanism, nanomolar potency, and proven ability to modulate the cGAS-TRIM41 axis offer researchers advanced control of genome integrity assays across cancer and aging models.

• Berberine Hydrochloride in Metabolic and Cardiovascular Rese

  2026-08-05

  Berberine Hydrochloride is redefining metabolic and cardiovascular disease modeling through its AMPK-mediated pathways and apoptotic regulation. This article delivers actionable experimental workflows, troubleshooting insights, and a strategic translation of the latest reference discoveries for research teams leveraging APExBIO’s trusted reagent.

• Applied Dovitinib (TKI-258) Workflows: RTK Inhibition in Can

  2026-08-04

  Dovitinib (TKI-258) stands out as a multitargeted RTK inhibitor enabling precise apoptosis induction and pathway mapping in complex cancer models. This guide delivers advanced experimental workflows, troubleshooting strategies, and key innovations for maximizing translational impact—anchored by cutting-edge cheminformatics and real-world protocol enhancements.

• Caspase-6 Inhibition: New Horizons for Translational Apoptos

  2026-08-04

  This thought-leadership article explores the mechanistic and translational significance of caspase-6 in apoptosis and viral immune evasion, highlighting Z-VEID-FMK as a precision tool for dissecting complex pathways. Integrating fresh evidence from PRRSV research and established translational models, we provide actionable guidance for researchers aiming to leverage caspase-6 inhibitors in apoptosis assays, neurodegeneration, and antiviral innovation.

• TRIM21 Drives Proliferation and Drug Resistance in Pituitary

  2026-08-03

  This study identifies TRIM21 as a key driver of cell proliferation and therapeutic resistance in pituitary adenomas through ERK1/2 ubiquitination and phosphorylation. The findings highlight TRIM21 as a promising therapeutic target and demonstrate that HDAC inhibitors such as Quisinostat can suppress TRIM21, thereby restoring drug sensitivity in resistant tumor models.

• SIS3 (Smad3 Inhibitor): Transforming Osteoarthritis and Fibr

  2026-08-03

  Explore how SIS3, a potent Smad3 inhibitor, advances precision fibrosis and osteoarthritis research through selective pathway targeting and practical assay insights. This article uniquely unpacks mechanistic findings and assay decision-making, setting it apart from prior reviews.

14937 records 1/996 page Next 12345 下5页 Last page